*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Atlanta, GA | Posted: May 18, 2022
Communications Officer
School of Public Policy | Sam Nunn School of International Affairs
Summary Sentence:
The article was published in "Current Opinion in Biomedical Engineering."
Full Summary:
The article was published in "Current Opinion in Biomedical Engineering."
Aaron Levine, Ivan Allen College Aaron Levine, associate professor in the School of Public Policy and associate dean for research and outreach in the Ivan Allen College of Liberal Arts, co-authored an article published in Current Opinion in Biomedical Engineering. The piece is titled “Commercial Autologous Cell Therapy: The Value of Real-Time Patient and Therapy Data.”
In it, the authors discuss the role that real-time data can play in autologous cell therapy manufacturing. They note that access to real-time data has already benefitted several industries and believe that the same could be true for that of cell therapy manufacturing.
“Several examples have illustrated that this value can be significant,” they write. “Moving toward a more flexible and adaptive manufacturing processes for autologous cell therapies would require changes to the current regulatory structure but could potentially help the industry improve clinical outcomes and manage costs.”
Read the full article at https://doi.org/10.1016/j.cobme.2022.100389.
